Clinical trial
Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV…
NCT00176033 · Heidelberg University, Other · Completed
Key facts
| NCT number | NCT00176033 |
|---|---|
| Title | Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra |
| Official title | Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra (Lopinavir/Ritonavir) and on the Concentration Relations Between Plasma, Blood Cells, Saliva and Urine |
| Lead sponsor | Heidelberg University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Healthy, Pharmacokinetics |
| Enrollment | 12 |
| Start date | Jan 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 13, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: